Active	Status	Sponsor type	Region	Phase	Filter
2 Active 1 Inactive 3 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes: « April » « 2025 » M T W T F S S 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4   - « April » « 2025 » M T W T F S S 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4   Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
brogidirsen (NS-089/NCNP-02) / Nippon Shinyaku, National Center of Neurology and Psychiatry
NCT05996003: NS-089/NCNP-02-201 in Boys With Duchenne Muscular Dystrophy (DMD)	Recruiting	2	20	US	NS-089/NCNP-02, Brogidirsen	NS Pharma, Inc., Nippon Shinyaku Co., Ltd.	Duchenne Muscular Dystrophy	11/25	11/25
NCT05135663: Extension Study of NS-089/NCNP-02 in DMD	Active, not recruiting	2	6	Japan	NS-089/NCNP-02	Nippon Shinyaku Co., Ltd.	Duchenne Muscular Dystrophy (DMD)	01/26	07/26

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
brogidirsen (NS-089/NCNP-02) / Nippon Shinyaku, National Center of Neurology and Psychiatry
NCT05996003: NS-089/NCNP-02-201 in Boys With Duchenne Muscular Dystrophy (DMD)	Recruiting	2	20	US	NS-089/NCNP-02, Brogidirsen	NS Pharma, Inc., Nippon Shinyaku Co., Ltd.	Duchenne Muscular Dystrophy	11/25	11/25
NCT05135663: Extension Study of NS-089/NCNP-02 in DMD	Active, not recruiting	2	6	Japan	NS-089/NCNP-02	Nippon Shinyaku Co., Ltd.	Duchenne Muscular Dystrophy (DMD)	01/26	07/26